nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—prostate gland—prostate cancer	0.0427	0.192	CbGeAlD
Framycetin—CXCR4—seminal vesicle—prostate cancer	0.0362	0.162	CbGeAlD
Framycetin—CXCR4—epithelium—prostate cancer	0.0314	0.141	CbGeAlD
Framycetin—CXCR4—renal system—prostate cancer	0.0291	0.131	CbGeAlD
Framycetin—CXCR4—urethra—prostate cancer	0.0286	0.129	CbGeAlD
Framycetin—CXCR4—bone marrow—prostate cancer	0.022	0.099	CbGeAlD
Framycetin—CXCR4—testis—prostate cancer	0.0188	0.0846	CbGeAlD
Framycetin—CXCR4—lymph node—prostate cancer	0.0136	0.0613	CbGeAlD
Framycetin—Eye infection—Estradiol—prostate cancer	0.0125	0.0393	CcSEcCtD
Framycetin—Ototoxicity—Docetaxel—prostate cancer	0.0125	0.0391	CcSEcCtD
Framycetin—Nerve injury—Prednisone—prostate cancer	0.00987	0.031	CcSEcCtD
Framycetin—Ulcerative keratitis—Prednisone—prostate cancer	0.00853	0.0268	CcSEcCtD
Framycetin—Cataract subcapsular—Prednisone—prostate cancer	0.00826	0.026	CcSEcCtD
Framycetin—Swelling—Degarelix—prostate cancer	0.00716	0.0225	CcSEcCtD
Framycetin—Nephropathy toxic—Mitoxantrone—prostate cancer	0.00629	0.0198	CcSEcCtD
Framycetin—Secondary infection—Epirubicin—prostate cancer	0.00574	0.018	CcSEcCtD
Framycetin—Secondary infection—Doxorubicin—prostate cancer	0.00531	0.0167	CcSEcCtD
Framycetin—Nephropathy toxic—Etoposide—prostate cancer	0.00524	0.0165	CcSEcCtD
Framycetin—Impaired healing—Prednisone—prostate cancer	0.00498	0.0157	CcSEcCtD
Framycetin—Sensitisation—Epirubicin—prostate cancer	0.00472	0.0148	CcSEcCtD
Framycetin—Sensitisation—Doxorubicin—prostate cancer	0.00437	0.0137	CcSEcCtD
Framycetin—Viral infection—Estradiol—prostate cancer	0.0043	0.0135	CcSEcCtD
Framycetin—Erythema—Flutamide—prostate cancer	0.00424	0.0133	CcSEcCtD
Framycetin—Swelling—Goserelin—prostate cancer	0.00403	0.0127	CcSEcCtD
Framycetin—Viral infection—Mitoxantrone—prostate cancer	0.004	0.0126	CcSEcCtD
Framycetin—Swelling—Conjugated Estrogens—prostate cancer	0.00399	0.0125	CcSEcCtD
Framycetin—Erythema—Degarelix—prostate cancer	0.00381	0.012	CcSEcCtD
Framycetin—Infection—Abiraterone—prostate cancer	0.00378	0.0119	CcSEcCtD
Framycetin—Anaphylactic shock—Estrone—prostate cancer	0.00374	0.0118	CcSEcCtD
Framycetin—Erythema—Cabazitaxel—prostate cancer	0.00359	0.0113	CcSEcCtD
Framycetin—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.00327	0.0103	CcSEcCtD
Framycetin—Swelling—Estradiol—prostate cancer	0.00319	0.01	CcSEcCtD
Framycetin—Anaphylactic shock—Degarelix—prostate cancer	0.00311	0.00976	CcSEcCtD
Framycetin—Swelling—Mitoxantrone—prostate cancer	0.00297	0.00935	CcSEcCtD
Framycetin—Infection—Cabazitaxel—prostate cancer	0.00291	0.00914	CcSEcCtD
Framycetin—Glaucoma—Prednisone—prostate cancer	0.00286	0.009	CcSEcCtD
Framycetin—Pruritus—Estramustine—prostate cancer	0.00277	0.00871	CcSEcCtD
Framycetin—Diarrhoea—Estramustine—prostate cancer	0.00268	0.00843	CcSEcCtD
Framycetin—Pruritus—Estrone—prostate cancer	0.00265	0.00832	CcSEcCtD
Framycetin—Diarrhoea—Abiraterone—prostate cancer	0.0026	0.00818	CcSEcCtD
Framycetin—Infection—Bicalutamide—prostate cancer	0.00249	0.00784	CcSEcCtD
Framycetin—Vomiting—Estramustine—prostate cancer	0.00249	0.00783	CcSEcCtD
Framycetin—Swelling—Etoposide—prostate cancer	0.00247	0.00778	CcSEcCtD
Framycetin—Pruritus—Nilutamide—prostate cancer	0.00246	0.00773	CcSEcCtD
Framycetin—Pruritus—Flutamide—prostate cancer	0.00245	0.0077	CcSEcCtD
Framycetin—Vomiting—Abiraterone—prostate cancer	0.00242	0.00761	CcSEcCtD
Framycetin—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.00241	0.00757	CcSEcCtD
Framycetin—Viral infection—Prednisone—prostate cancer	0.00239	0.0075	CcSEcCtD
Framycetin—Vomiting—Estrone—prostate cancer	0.00238	0.00748	CcSEcCtD
Framycetin—Diarrhoea—Nilutamide—prostate cancer	0.00238	0.00748	CcSEcCtD
Framycetin—Diarrhoea—Flutamide—prostate cancer	0.00237	0.00744	CcSEcCtD
Framycetin—Nausea—Estramustine—prostate cancer	0.00233	0.00732	CcSEcCtD
Framycetin—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00231	0.00727	CcSEcCtD
Framycetin—Hypersensitivity—Degarelix—prostate cancer	0.00229	0.00719	CcSEcCtD
Framycetin—Nausea—Estrone—prostate cancer	0.00222	0.00699	CcSEcCtD
Framycetin—Vomiting—Nilutamide—prostate cancer	0.00221	0.00695	CcSEcCtD
Framycetin—Vomiting—Flutamide—prostate cancer	0.0022	0.00692	CcSEcCtD
Framycetin—Pruritus—Degarelix—prostate cancer	0.0022	0.00691	CcSEcCtD
Framycetin—Hypersensitivity—Cabazitaxel—prostate cancer	0.00216	0.00678	CcSEcCtD
Framycetin—Erythema—Goserelin—prostate cancer	0.00214	0.00672	CcSEcCtD
Framycetin—Diarrhoea—Degarelix—prostate cancer	0.00213	0.00668	CcSEcCtD
Framycetin—Erythema—Conjugated Estrogens—prostate cancer	0.00212	0.00666	CcSEcCtD
Framycetin—Infection—Ethinyl Estradiol—prostate cancer	0.00211	0.00663	CcSEcCtD
Framycetin—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00208	0.00653	CcSEcCtD
Framycetin—Nausea—Nilutamide—prostate cancer	0.00207	0.00649	CcSEcCtD
Framycetin—Swelling—Docetaxel—prostate cancer	0.00206	0.00646	CcSEcCtD
Framycetin—Nausea—Flutamide—prostate cancer	0.00206	0.00646	CcSEcCtD
Framycetin—Diarrhoea—Cabazitaxel—prostate cancer	0.002	0.00629	CcSEcCtD
Framycetin—Swelling—Capecitabine—prostate cancer	0.00199	0.00626	CcSEcCtD
Framycetin—Vomiting—Degarelix—prostate cancer	0.00198	0.00621	CcSEcCtD
Framycetin—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00194	0.0061	CcSEcCtD
Framycetin—Viral infection—Epirubicin—prostate cancer	0.00187	0.00587	CcSEcCtD
Framycetin—Vomiting—Cabazitaxel—prostate cancer	0.00186	0.00585	CcSEcCtD
Framycetin—Hypersensitivity—Bicalutamide—prostate cancer	0.00185	0.00581	CcSEcCtD
Framycetin—Nausea—Degarelix—prostate cancer	0.00185	0.0058	CcSEcCtD
Framycetin—Pruritus—Bicalutamide—prostate cancer	0.00178	0.00558	CcSEcCtD
Framycetin—Anaphylactic shock—Goserelin—prostate cancer	0.00175	0.00549	CcSEcCtD
Framycetin—Nausea—Cabazitaxel—prostate cancer	0.00174	0.00546	CcSEcCtD
Framycetin—Infection—Goserelin—prostate cancer	0.00173	0.00545	CcSEcCtD
Framycetin—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00173	0.00544	CcSEcCtD
Framycetin—Viral infection—Doxorubicin—prostate cancer	0.00173	0.00543	CcSEcCtD
Framycetin—Infection—Conjugated Estrogens—prostate cancer	0.00172	0.0054	CcSEcCtD
Framycetin—Diarrhoea—Bicalutamide—prostate cancer	0.00172	0.0054	CcSEcCtD
Framycetin—Erythema—Estradiol—prostate cancer	0.0017	0.00533	CcSEcCtD
Framycetin—Vomiting—Bicalutamide—prostate cancer	0.0016	0.00502	CcSEcCtD
Framycetin—Erythema—Mitoxantrone—prostate cancer	0.00158	0.00497	CcSEcCtD
Framycetin—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00156	0.00491	CcSEcCtD
Framycetin—Pruritus—Ethinyl Estradiol—prostate cancer	0.0015	0.00472	CcSEcCtD
Framycetin—Nausea—Bicalutamide—prostate cancer	0.00149	0.00469	CcSEcCtD
Framycetin—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00145	0.00456	CcSEcCtD
Framycetin—Anaphylactic shock—Estradiol—prostate cancer	0.00138	0.00435	CcSEcCtD
Framycetin—Infection—Estradiol—prostate cancer	0.00138	0.00432	CcSEcCtD
Framycetin—Vomiting—Ethinyl Estradiol—prostate cancer	0.00135	0.00424	CcSEcCtD
Framycetin—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00129	0.00405	CcSEcCtD
Framycetin—Hypersensitivity—Goserelin—prostate cancer	0.00129	0.00404	CcSEcCtD
Framycetin—Infection—Mitoxantrone—prostate cancer	0.00128	0.00403	CcSEcCtD
Framycetin—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00127	0.00401	CcSEcCtD
Framycetin—CXCR4—Disease—NAGLU—prostate cancer	0.00126	0.00275	CbGpPWpGaD
Framycetin—Nausea—Ethinyl Estradiol—prostate cancer	0.00126	0.00396	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GRPR—prostate cancer	0.00125	0.00272	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—ERCC2—prostate cancer	0.00124	0.00271	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—STAT3—prostate cancer	0.00124	0.0027	CbGpPWpGaD
Framycetin—Pruritus—Goserelin—prostate cancer	0.00124	0.00388	CcSEcCtD
Framycetin—Pruritus—Conjugated Estrogens—prostate cancer	0.00122	0.00385	CcSEcCtD
Framycetin—Diarrhoea—Goserelin—prostate cancer	0.00119	0.00376	CcSEcCtD
Framycetin—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00118	0.00372	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—PTHLH—prostate cancer	0.00115	0.0025	CbGpPWpGaD
Framycetin—CXCR4—Disease—HSD17B1—prostate cancer	0.00114	0.00249	CbGpPWpGaD
Framycetin—CXCR4—Disease—CTBP2—prostate cancer	0.00114	0.00249	CbGpPWpGaD
Framycetin—CXCR4—Disease—DNAJC3—prostate cancer	0.00114	0.00249	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—MC2R—prostate cancer	0.00113	0.00246	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—ADRB2—prostate cancer	0.00111	0.00242	CbGpPWpGaD
Framycetin—Vomiting—Goserelin—prostate cancer	0.00111	0.00349	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—OR51E2—prostate cancer	0.00111	0.00241	CbGpPWpGaD
Framycetin—Vomiting—Conjugated Estrogens—prostate cancer	0.0011	0.00346	CcSEcCtD
Framycetin—Erythema—Docetaxel—prostate cancer	0.00109	0.00343	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—ANXA1—prostate cancer	0.00108	0.00235	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—WNT4—prostate cancer	0.00108	0.00234	CbGpPWpGaD
Framycetin—Anaphylactic shock—Etoposide—prostate cancer	0.00107	0.00337	CcSEcCtD
Framycetin—Infection—Etoposide—prostate cancer	0.00107	0.00335	CcSEcCtD
Framycetin—Erythema—Capecitabine—prostate cancer	0.00106	0.00332	CcSEcCtD
Framycetin—Nausea—Goserelin—prostate cancer	0.00104	0.00326	CcSEcCtD
Framycetin—Nausea—Conjugated Estrogens—prostate cancer	0.00103	0.00323	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—MC2R—prostate cancer	0.00103	0.00224	CbGpPWpGaD
Framycetin—Hypersensitivity—Estradiol—prostate cancer	0.00102	0.00321	CcSEcCtD
Framycetin—CXCR4—Disease—IL17RD—prostate cancer	0.00102	0.00222	CbGpPWpGaD
Framycetin—CXCR4—Disease—B4GALT4—prostate cancer	0.00102	0.00222	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BMPR1B—prostate cancer	0.00101	0.0022	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CALCA—prostate cancer	0.00101	0.0022	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PENK—prostate cancer	0.00101	0.00219	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL12—prostate cancer	0.000988	0.00215	CbGpPWpGaD
Framycetin—Pruritus—Estradiol—prostate cancer	0.000979	0.00308	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CA—prostate cancer	0.000977	0.00213	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—AKT1—prostate cancer	0.000968	0.00211	CbGpPWpGaD
Framycetin—Hypersensitivity—Mitoxantrone—prostate cancer	0.00095	0.00299	CcSEcCtD
Framycetin—Diarrhoea—Estradiol—prostate cancer	0.000947	0.00298	CcSEcCtD
Framycetin—Erythema—Prednisone—prostate cancer	0.000942	0.00296	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—RGS17—prostate cancer	0.000941	0.00205	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PENK—prostate cancer	0.000915	0.00199	CbGpPWpGaD
Framycetin—CXCR4—Disease—WNT4—prostate cancer	0.000908	0.00198	CbGpPWpGaD
Framycetin—Anaphylactic shock—Docetaxel—prostate cancer	0.000892	0.0028	CcSEcCtD
Framycetin—Infection—Docetaxel—prostate cancer	0.000886	0.00278	CcSEcCtD
Framycetin—Diarrhoea—Mitoxantrone—prostate cancer	0.000883	0.00277	CcSEcCtD
Framycetin—Vomiting—Estradiol—prostate cancer	0.00088	0.00277	CcSEcCtD
Framycetin—Infection—Capecitabine—prostate cancer	0.000858	0.0027	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—GNRH1—prostate cancer	0.000857	0.00187	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—VIP—prostate cancer	0.000857	0.00187	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—ADRB2—prostate cancer	0.000848	0.00185	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RLN2—prostate cancer	0.000839	0.00183	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—LPAR1—prostate cancer	0.00083	0.00181	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRP—prostate cancer	0.00083	0.00181	CbGpPWpGaD
Framycetin—Nausea—Estradiol—prostate cancer	0.000822	0.00258	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—PLCB2—prostate cancer	0.000821	0.00179	CbGpPWpGaD
Framycetin—Vomiting—Mitoxantrone—prostate cancer	0.00082	0.00258	CcSEcCtD
Framycetin—CXCR4—Disease—LDHB—prostate cancer	0.000814	0.00177	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPL12—prostate cancer	0.000814	0.00177	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL8—prostate cancer	0.000801	0.00175	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CTBP2—prostate cancer	0.0008	0.00174	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HSD17B1—prostate cancer	0.0008	0.00174	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—AKT1—prostate cancer	0.000798	0.00174	CbGpPWpGaD
Framycetin—Hypersensitivity—Etoposide—prostate cancer	0.00079	0.00248	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—PDE4D—prostate cancer	0.000784	0.00171	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—VIP—prostate cancer	0.000778	0.00169	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GNRH1—prostate cancer	0.000778	0.00169	CbGpPWpGaD
Framycetin—CXCR4—Disease—TCN2—prostate cancer	0.000772	0.00168	CbGpPWpGaD
Framycetin—Anaphylactic shock—Prednisone—prostate cancer	0.000769	0.00242	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PLXNB1—prostate cancer	0.000767	0.00167	CbGpPWpGaD
Framycetin—Nausea—Mitoxantrone—prostate cancer	0.000766	0.00241	CcSEcCtD
Framycetin—Infection—Prednisone—prostate cancer	0.000764	0.0024	CcSEcCtD
Framycetin—Pruritus—Etoposide—prostate cancer	0.000759	0.00239	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—LPAR1—prostate cancer	0.000753	0.00164	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GRP—prostate cancer	0.000753	0.00164	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PLCB2—prostate cancer	0.000746	0.00162	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GNG5—prostate cancer	0.000745	0.00162	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRPR—prostate cancer	0.000738	0.00161	CbGpPWpGaD
Framycetin—Erythema—Epirubicin—prostate cancer	0.000737	0.00232	CcSEcCtD
Framycetin—Diarrhoea—Etoposide—prostate cancer	0.000734	0.00231	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CX3CL1—prostate cancer	0.000731	0.00159	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL17RD—prostate cancer	0.000713	0.00155	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PDE4D—prostate cancer	0.000712	0.00155	CbGpPWpGaD
Framycetin—Vomiting—Etoposide—prostate cancer	0.000682	0.00214	CcSEcCtD
Framycetin—Erythema—Doxorubicin—prostate cancer	0.000682	0.00214	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GNG5—prostate cancer	0.000677	0.00147	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL8—prostate cancer	0.000676	0.00147	CbGpPWpGaD
Framycetin—Hypersensitivity—Docetaxel—prostate cancer	0.000657	0.00206	CcSEcCtD
Framycetin—CXCR4—Disease—GSTO1—prostate cancer	0.000656	0.00143	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PTHLH—prostate cancer	0.000649	0.00141	CbGpPWpGaD
Framycetin—Nausea—Etoposide—prostate cancer	0.000637	0.002	CcSEcCtD
Framycetin—Hypersensitivity—Capecitabine—prostate cancer	0.000636	0.002	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—WNT4—prostate cancer	0.000636	0.00138	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JUP—prostate cancer	0.000636	0.00138	CbGpPWpGaD
Framycetin—Pruritus—Docetaxel—prostate cancer	0.000631	0.00198	CcSEcCtD
Framycetin—CXCR4—Disease—LRP2—prostate cancer	0.000629	0.00137	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPL10—prostate cancer	0.000617	0.00134	CbGpPWpGaD
Framycetin—CXCR4—Disease—P4HB—prostate cancer	0.000617	0.00134	CbGpPWpGaD
Framycetin—CXCR4—Disease—EIF2AK2—prostate cancer	0.000617	0.00134	CbGpPWpGaD
Framycetin—Pruritus—Capecitabine—prostate cancer	0.000611	0.00192	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—ANXA1—prostate cancer	0.00061	0.00133	CbGpPWpGaD
Framycetin—Diarrhoea—Docetaxel—prostate cancer	0.00061	0.00192	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—RALBP1—prostate cancer	0.000606	0.00132	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MC2R—prostate cancer	0.000606	0.00132	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIST1H2BG—prostate cancer	0.000606	0.00132	CbGpPWpGaD
Framycetin—Anaphylactic shock—Epirubicin—prostate cancer	0.000601	0.00189	CcSEcCtD
Framycetin—Infection—Epirubicin—prostate cancer	0.000597	0.00188	CcSEcCtD
Framycetin—Diarrhoea—Capecitabine—prostate cancer	0.000591	0.00186	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PTHLH—prostate cancer	0.00059	0.00128	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIST1H4H—prostate cancer	0.000585	0.00127	CbGpPWpGaD
Framycetin—CXCR4—Disease—NPPA—prostate cancer	0.000585	0.00127	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKACB—prostate cancer	0.000577	0.00126	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CALCA—prostate cancer	0.000572	0.00124	CbGpPWpGaD
Framycetin—Vomiting—Docetaxel—prostate cancer	0.000567	0.00178	CcSEcCtD
Framycetin—Hypersensitivity—Prednisone—prostate cancer	0.000567	0.00178	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PPP3CA—prostate cancer	0.000562	0.00122	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL12—prostate cancer	0.000558	0.00122	CbGpPWpGaD
Framycetin—Anaphylactic shock—Doxorubicin—prostate cancer	0.000556	0.00175	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—ANXA1—prostate cancer	0.000554	0.00121	CbGpPWpGaD
Framycetin—Infection—Doxorubicin—prostate cancer	0.000553	0.00174	CcSEcCtD
Framycetin—Vomiting—Capecitabine—prostate cancer	0.000549	0.00173	CcSEcCtD
Framycetin—Pruritus—Prednisone—prostate cancer	0.000544	0.00171	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PENK—prostate cancer	0.00054	0.00118	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000538	0.00117	CbGpPWpGaD
Framycetin—Nausea—Docetaxel—prostate cancer	0.00053	0.00166	CcSEcCtD
Framycetin—Diarrhoea—Prednisone—prostate cancer	0.000526	0.00165	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CALCA—prostate cancer	0.000519	0.00113	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GHR—prostate cancer	0.000516	0.00112	CbGpPWpGaD
Framycetin—Nausea—Capecitabine—prostate cancer	0.000513	0.00161	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—PRKCQ—prostate cancer	0.000509	0.00111	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL12—prostate cancer	0.000507	0.0011	CbGpPWpGaD
Framycetin—CXCR4—Disease—B2M—prostate cancer	0.000497	0.00108	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFBR1—prostate cancer	0.000497	0.00108	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NRP1—prostate cancer	0.000494	0.00108	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKR1C3—prostate cancer	0.000489	0.00107	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPS19—prostate cancer	0.000489	0.00107	CbGpPWpGaD
Framycetin—Vomiting—Prednisone—prostate cancer	0.000489	0.00154	CcSEcCtD
Framycetin—CXCR4—Disease—PRKACB—prostate cancer	0.000487	0.00106	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ADRB2—prostate cancer	0.000479	0.00104	CbGpPWpGaD
Framycetin—CXCR4—Disease—PPP3CA—prostate cancer	0.000474	0.00103	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—VAV3—prostate cancer	0.000467	0.00102	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCQ—prostate cancer	0.000463	0.00101	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VIP—prostate cancer	0.00046	0.001	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GNRH1—prostate cancer	0.00046	0.001	CbGpPWpGaD
Framycetin—CXCR4—Disease—PRKCZ—prostate cancer	0.000459	0.000999	CbGpPWpGaD
Framycetin—Nausea—Prednisone—prostate cancer	0.000457	0.00144	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—ITPR1—prostate cancer	0.000453	0.000986	CbGpPWpGaD
Framycetin—CXCR4—Disease—CALR—prostate cancer	0.000451	0.000982	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRP—prostate cancer	0.000445	0.000969	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LPAR1—prostate cancer	0.000445	0.000969	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGFR4—prostate cancer	0.000443	0.000965	CbGpPWpGaD
Framycetin—CXCR4—Disease—PARP1—prostate cancer	0.000443	0.000965	CbGpPWpGaD
Framycetin—Hypersensitivity—Epirubicin—prostate cancer	0.000443	0.00139	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PLCB2—prostate cancer	0.000441	0.000959	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LRP2—prostate cancer	0.000441	0.000959	CbGpPWpGaD
Framycetin—CXCR4—Disease—CALCA—prostate cancer	0.000438	0.000953	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ADRB2—prostate cancer	0.000435	0.000947	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CX3CL1—prostate cancer	0.000432	0.000941	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—P4HB—prostate cancer	0.000432	0.000941	CbGpPWpGaD
Framycetin—Pruritus—Epirubicin—prostate cancer	0.000425	0.00134	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—VAV3—prostate cancer	0.000424	0.000924	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIST1H2BG—prostate cancer	0.000424	0.000923	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRB7—prostate cancer	0.00042	0.000915	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDE4D—prostate cancer	0.00042	0.000915	CbGpPWpGaD
Framycetin—CXCR4—Disease—HSPA1A—prostate cancer	0.00042	0.000914	CbGpPWpGaD
Framycetin—Diarrhoea—Epirubicin—prostate cancer	0.000411	0.00129	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—ITPR1—prostate cancer	0.000411	0.000896	CbGpPWpGaD
Framycetin—Hypersensitivity—Doxorubicin—prostate cancer	0.00041	0.00129	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—HIST1H4H—prostate cancer	0.00041	0.000892	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—prostate cancer	0.000409	0.000891	CbGpPWpGaD
Framycetin—CXCR4—Disease—CASP9—prostate cancer	0.000403	0.000877	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GNG5—prostate cancer	0.0004	0.000871	CbGpPWpGaD
Framycetin—Pruritus—Doxorubicin—prostate cancer	0.000394	0.00124	CcSEcCtD
Framycetin—CXCR4—Disease—PRKCQ—prostate cancer	0.00039	0.00085	CbGpPWpGaD
Framycetin—Vomiting—Epirubicin—prostate cancer	0.000382	0.0012	CcSEcCtD
Framycetin—Diarrhoea—Doxorubicin—prostate cancer	0.000381	0.0012	CcSEcCtD
Framycetin—CXCR4—Disease—FGF10—prostate cancer	0.000371	0.000807	CbGpPWpGaD
Framycetin—Nausea—Epirubicin—prostate cancer	0.000357	0.00112	CcSEcCtD
Framycetin—Vomiting—Doxorubicin—prostate cancer	0.000354	0.00111	CcSEcCtD
Framycetin—CXCR4—Disease—TGFBR2—prostate cancer	0.000353	0.000768	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFBR1—prostate cancer	0.000348	0.000758	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTHLH—prostate cancer	0.000348	0.000758	CbGpPWpGaD
Framycetin—CXCR4—Disease—ITPR1—prostate cancer	0.000347	0.000756	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKR1C3—prostate cancer	0.000343	0.000746	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKACB—prostate cancer	0.000341	0.000742	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—THBS1—prostate cancer	0.000332	0.000723	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PPP3CA—prostate cancer	0.000332	0.000723	CbGpPWpGaD
Framycetin—Nausea—Doxorubicin—prostate cancer	0.000331	0.00104	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—ANXA1—prostate cancer	0.000327	0.000713	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCZ—prostate cancer	0.000321	0.0007	CbGpPWpGaD
Framycetin—CXCR4—Disease—LPL—prostate cancer	0.000318	0.000693	CbGpPWpGaD
Framycetin—CXCR4—Disease—PDGFRB—prostate cancer	0.000315	0.000687	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CG—prostate cancer	0.000314	0.000684	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGFR4—prostate cancer	0.00031	0.000676	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PARP1—prostate cancer	0.00031	0.000676	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CALCA—prostate cancer	0.000307	0.000668	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERCC2—prostate cancer	0.000305	0.000664	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL12—prostate cancer	0.000299	0.000652	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB3—prostate cancer	0.000298	0.000649	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGFR2—prostate cancer	0.000298	0.000648	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTHFR—prostate cancer	0.000286	0.000624	CbGpPWpGaD
Framycetin—CXCR4—Disease—TERT—prostate cancer	0.000286	0.000622	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CG—prostate cancer	0.000285	0.000621	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP9—prostate cancer	0.000282	0.000614	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CD—prostate cancer	0.000276	0.000601	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCQ—prostate cancer	0.000273	0.000595	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NGFR—prostate cancer	0.000273	0.000595	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIF1A—prostate cancer	0.000273	0.000595	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAP3K7—prostate cancer	0.00027	0.000588	CbGpPWpGaD
Framycetin—CXCR4—Disease—CAV1—prostate cancer	0.000264	0.000575	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF10—prostate cancer	0.00026	0.000565	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADRB2—prostate cancer	0.000257	0.000559	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—JAK2—prostate cancer	0.000253	0.000552	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAP2K1—prostate cancer	0.000252	0.00055	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CD—prostate cancer	0.000251	0.000546	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VAV3—prostate cancer	0.000251	0.000546	CbGpPWpGaD
Framycetin—CXCR4—Disease—BAD—prostate cancer	0.000249	0.000541	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFBR2—prostate cancer	0.000247	0.000538	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ITPR1—prostate cancer	0.000243	0.000529	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CB—prostate cancer	0.000241	0.000524	CbGpPWpGaD
Framycetin—CXCR4—Disease—APC—prostate cancer	0.000241	0.000524	CbGpPWpGaD
Framycetin—CXCR4—Disease—IRS1—prostate cancer	0.000238	0.000518	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGF—prostate cancer	0.000238	0.000518	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1R—prostate cancer	0.000232	0.000506	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—prostate cancer	0.000231	0.000504	CbGpPWpGaD
Framycetin—CXCR4—Disease—GSK3B—prostate cancer	0.000231	0.000503	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—JAK2—prostate cancer	0.00023	0.000501	CbGpPWpGaD
Framycetin—CXCR4—Disease—INS—prostate cancer	0.000228	0.000496	CbGpPWpGaD
Framycetin—CXCR4—Disease—CREBBP—prostate cancer	0.000223	0.000486	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LPL—prostate cancer	0.000223	0.000485	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2—prostate cancer	0.000221	0.000481	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDGFRB—prostate cancer	0.000221	0.000481	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CB—prostate cancer	0.000219	0.000476	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ITGB3—prostate cancer	0.000215	0.000469	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAP2K1—prostate cancer	0.000213	0.000464	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CD—prostate cancer	0.000212	0.000461	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—prostate cancer	0.00021	0.000457	CbGpPWpGaD
Framycetin—CXCR4—Disease—SERPINE1—prostate cancer	0.000209	0.000456	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB3—prostate cancer	0.000209	0.000454	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGFR2—prostate cancer	0.000208	0.000454	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF2—prostate cancer	0.000203	0.000441	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2—prostate cancer	0.000201	0.000437	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TERT—prostate cancer	0.0002	0.000436	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS3—prostate cancer	0.0002	0.000435	CbGpPWpGaD
Framycetin—CXCR4—Disease—JAK2—prostate cancer	0.000194	0.000423	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIF1A—prostate cancer	0.000191	0.000417	CbGpPWpGaD
Framycetin—CXCR4—Disease—MDM2—prostate cancer	0.00019	0.000413	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB2—prostate cancer	0.000187	0.000407	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LEP—prostate cancer	0.000187	0.000407	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CAV1—prostate cancer	0.000185	0.000403	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CB—prostate cancer	0.000184	0.000402	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KDR—prostate cancer	0.000183	0.000398	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—prostate cancer	0.000183	0.000398	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ESR1—prostate cancer	0.000178	0.000388	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BAD—prostate cancer	0.000174	0.000379	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1B—prostate cancer	0.000173	0.000377	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APC—prostate cancer	0.000169	0.000367	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CG—prostate cancer	0.000169	0.000367	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGF—prostate cancer	0.000167	0.000363	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IRS1—prostate cancer	0.000167	0.000363	CbGpPWpGaD
Framycetin—CXCR4—Disease—CTNNB1—prostate cancer	0.000163	0.000356	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GSK3B—prostate cancer	0.000162	0.000352	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1A—prostate cancer	0.00016	0.000348	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—INS—prostate cancer	0.00016	0.000347	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTEN—prostate cancer	0.000159	0.000347	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CREBBP—prostate cancer	0.000156	0.00034	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1—prostate cancer	0.000154	0.000336	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EGFR—prostate cancer	0.000154	0.000334	CbGpPWpGaD
Framycetin—CXCR4—Disease—EP300—prostate cancer	0.000152	0.000331	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAP2K1—prostate cancer	0.000149	0.000325	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CD—prostate cancer	0.000148	0.000323	CbGpPWpGaD
Framycetin—CXCR4—Disease—SRC—prostate cancer	0.000148	0.000322	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CA—prostate cancer	0.000147	0.00032	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SERPINE1—prostate cancer	0.000147	0.000319	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KRAS—prostate cancer	0.000145	0.000316	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT3—prostate cancer	0.000143	0.00031	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF2—prostate cancer	0.000142	0.000309	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOS3—prostate cancer	0.00014	0.000305	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JAK2—prostate cancer	0.000136	0.000296	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CA—prostate cancer	0.000133	0.00029	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MDM2—prostate cancer	0.000133	0.000289	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—prostate cancer	0.000132	0.000288	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFB1—prostate cancer	0.000132	0.000288	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB2—prostate cancer	0.000131	0.000285	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGFR—prostate cancer	0.00013	0.000282	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CB—prostate cancer	0.000129	0.000281	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—prostate cancer	0.000124	0.00027	CbGpPWpGaD
Framycetin—CXCR4—Disease—KRAS—prostate cancer	0.000122	0.000266	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1B—prostate cancer	0.000121	0.000264	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—prostate cancer	0.00012	0.000261	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP3—prostate cancer	0.000119	0.000259	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2—prostate cancer	0.000119	0.000258	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—prostate cancer	0.000118	0.000257	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCND1—prostate cancer	0.000116	0.000252	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CTNNB1—prostate cancer	0.000114	0.000249	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CA—prostate cancer	0.000112	0.000245	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—prostate cancer	0.000112	0.000244	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1A—prostate cancer	0.000112	0.000244	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTEN—prostate cancer	0.000112	0.000243	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—prostate cancer	0.000109	0.000237	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EP300—prostate cancer	0.000106	0.000232	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SRC—prostate cancer	0.000103	0.000225	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—prostate cancer	0.000101	0.000219	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT3—prostate cancer	9.98e-05	0.000217	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—prostate cancer	9.95e-05	0.000217	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—prostate cancer	9.27e-05	0.000202	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFB1—prostate cancer	9.25e-05	0.000201	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—prostate cancer	9.18e-05	0.0002	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGFR—prostate cancer	9.07e-05	0.000198	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KRAS—prostate cancer	8.57e-05	0.000187	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CA—prostate cancer	7.87e-05	0.000171	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—prostate cancer	7.62e-05	0.000166	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—prostate cancer	6.97e-05	0.000152	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—prostate cancer	6.43e-05	0.00014	CbGpPWpGaD
